Position in ACIU
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,072,952
+$402,676 QoQ
Shares Held
390,165
+82.8% QoQ
Ownership
0.383%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 72.90864121589584.ToString("F0")%
Shared 23.996770597055093.ToString("F0")%
None 3.094588187049069.ToString("F0")%
Common Shares in ACIU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. ACIU ranks #141 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in ACIU
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,072,952 | 390,165 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $670,276 | 213,464 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $511,849 | 177,111 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $403,331 | 198,686 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $444,232 | 237,558 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $354,806 | 131,410 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $215,655 | 57,052 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $240,189 | 60,198 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $176,865 | 59,752 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $298,760 | 59,752 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $170,293 | 59,752 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $180,112 | 60,952 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $108,217 | 46,247 | Shares | Sole | 2023-05-12 | |
| 2022-06-30 | $45,871 | 12,707 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $50,828 | 12,707 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $62,899 | 12,707 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $85,263 | 12,707 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $100,766 | 12,707 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $96,700 | 12,707 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $65,695 | 12,707 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $62,010 | 12,707 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $85,518 | 12,707 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $78,027 | 11,292 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||